DNA Link (127120) Stock Overview

DNA Link, Inc. focuses on the research and development of genomic services in the bio and genomic analysis industries in Korea. Its next generation sequencing services include De Novo, Exome, mRNA, small RNA, Isoform and chip/MEDIP/Methyl Capture sequencing, as well as whole genome and target resequencing. The company also provides DNA, RNA, The Agilent Human Genome comparative genomic hybridization, and copy-number variations analysis services. In addition, it offers genotyping and bioinformatics services. In addition, the company offers DNAGPS, a personal genomics (PGX) solution; and AccuID, a personal identification microarray system. DNA Link, Inc. was founded in 2000 and is based in Seoul, South Korea.